Advance purchase agreement for the reservation and supply of pandemic influenza vaccine

Beskrivelse fra ordregiveren

The purpose of this tender is to ensure fast delivery of pandemic influenza vaccines in the event of an influenza pandemic during the contract period. The contract (advance purchase agreement) regards reservation of the supplier’s production capacity and the contract will contain an option for purchase of pandemic influenza vaccine in the event of an influenza pandemic called by the WHO during the contract period. The reserved volume of pandemic vaccine is expected to be 7.6 million doses; however, the number of doses may be reduced by SSI as described in the tender documents. SSI expects that the Agreement cannot be awarded without prior negotiations with potential suppliers due to the specific circumstances related to the nature and the complexity of the Agreement and the legal and financial aspects and the associated risks. In essence, the procedure encompasses a complex advance purchase agreement, and SSI is dependent on further information from potential suppliers in order to establish a complete and adequate set of terms and conditions in accordance with what the market operators are able to meet. This makes it necessary for SSI to be able to negotiate various as-pects of both the tender documents and the tenders received and potentially make various changes to the tender documents. Hence, the procurement will be conducted as a negotiated procedure pursuant to the Danish Procurement Act (udbudsloven). All terms and requirements that are not minimum requirements may be subject to negotiation and may be changed or withdrawn during the tender procedure according to SSI’s decision. Thus, SSI encourages all economic operators who comply with the minimum requirements (stated in the Tender Specification, paragraph 5) to apply for prequalification, even if the economic operator cannot comply with other terms and requirements.

Andre bekendtgørelser fra Statens Serum Institut

• Udbud af Kontrakt vedrørende transport og distribution for Statens Serum Institut i Danmark (1) Statens Serum Institut · 6. november 2026 · frist 8. december 2026 · ca. 60.000.000 kr.
• Rammekontrakt om levering af MFR-vaccine 2026 – 2030 Statens Serum Institut · 29. oktober 2026
• Purchase of a new VHP pass through decontamination chamber Statens Serum Institut · 8. oktober 2026 · 4.178.214 kr.
• Rammekontrakt om levering af MFR-vaccine 2026 – 2030 Statens Serum Institut · 11. august 2026 · frist 10. september 2026
• Hepatitis vacciner 2026-2030 Statens Serum Institut · 25. juni 2026
• Udbud af HPV-vacciner 2026-2030 Statens Serum Institut · 25. juni 2026